Regulators have historically struggled to halt complex and non-traditional tie-ups. That could change with new guidelines, as the Biden administration increases scrutiny of healthcare M&A, antitrust experts said.
Regulators have historically struggled to halt complex and non-traditional tie-ups. That could change with new guidelines, as the Biden administration increases scrutiny of healthcare M&A, antitrust experts said.
Copyright © 2024 | WordPress Theme by MH Themes